BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 25516667)

  • 21. Serum Interleukin-33 level in Saudi children with inflammatory bowel disease.
    Saadah OI; Al-Harthi SE; Al-Mughales JA; Bin-Taleb YY; Baeshen RS
    Int J Clin Exp Pathol; 2015; 8(12):16000-6. PubMed ID: 26884875
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of urban/rural and coastal/inland environment on the prevalence, phenotype, and clinical course of inflammatory bowel disease patients from northwest of Spain: a cross-sectional study.
    Carpio D; Barreiro-de Acosta M; Echarri A; Pereira S; Castro J; Ferreiro R; Lorenzo A;
    Eur J Gastroenterol Hepatol; 2015 Sep; 27(9):1030-7. PubMed ID: 26049704
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A prospective randomized observer-blind 2-year trial of azathioprine monotherapy versus azathioprine and olsalazine for the maintenance of remission of steroid-dependent ulcerative colitis.
    Mantzaris GJ; Sfakianakis M; Archavlis E; Petraki K; Christidou A; Karagiannidis A; Triadaphyllou G
    Am J Gastroenterol; 2004 Jun; 99(6):1122-8. PubMed ID: 15180735
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term assessment of clinical response to adalimumab therapy in refractory ulcerative colitis.
    Hussey M; Mc Garrigle R; Kennedy U; Holleran G; Kevans D; Ryan B; Breslin N; Mahmud N; McNamara D
    Eur J Gastroenterol Hepatol; 2016 Feb; 28(2):217-21. PubMed ID: 26587866
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Presenting features and disease course of pediatric ulcerative colitis.
    Aloi M; D'Arcangelo G; Pofi F; Vassallo F; Rizzo V; Nuti F; Di Nardo G; Pierdomenico M; Viola F; Cucchiara S
    J Crohns Colitis; 2013 Dec; 7(11):e509-15. PubMed ID: 23583691
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Natural history of elderly-onset inflammatory bowel disease: a population-based cohort study.
    Charpentier C; Salleron J; Savoye G; Fumery M; Merle V; Laberenne JE; Vasseur F; Dupas JL; Cortot A; Dauchet L; Peyrin-Biroulet L; Lerebours E; Colombel JF; Gower-Rousseau C
    Gut; 2014 Mar; 63(3):423-32. PubMed ID: 23408350
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of new-onset ulcerative colitis and ulcerative proctitis: a retrospective study.
    Richter JM; Kushkuley S; Barrett JA; Oster G
    Aliment Pharmacol Ther; 2012 Aug; 36(3):248-56. PubMed ID: 22690748
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ulcerative proctitis is a frequent location of paediatric-onset UC and not a minor disease: a population-based study.
    Hochart A; Gower-Rousseau C; Sarter H; Fumery M; Ley D; Spyckerelle C; Peyrin-Biroulet L; Laberenne JE; Vasseur F; Savoye G; Turck D;
    Gut; 2017 Nov; 66(11):1912-1917. PubMed ID: 27489240
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-Term Benefit of Mesalamine Granules for Patients Who Achieved Corticosteroid-Induced Ulcerative Colitis Remission.
    Lichtenstein GR; Gordon GL; Zakko S; Murthy U; Sedghi S; Pruitt R; Barrett AC; Bortey E; Paterson C; Forbes WP
    Dig Dis Sci; 2016 Jan; 61(1):221-9. PubMed ID: 26563167
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical presentation and disease course of inflammatory bowel disease differs by race in a large tertiary care hospital.
    Sofia MA; Rubin DT; Hou N; Pekow J
    Dig Dis Sci; 2014 Sep; 59(9):2228-35. PubMed ID: 24752402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of infliximab in treating patients with ulcerative colitis: experiences from a single medical center in southern China.
    Zhou YL; Xie S; Wang P; Zhang T; Lin MY; Tan JS; Zhi FC; Jiang B; Chen Y
    J Dig Dis; 2014 Sep; 15(9):483-90. PubMed ID: 24828856
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Granulo-monocyto apheresis is more effective in mild ulcerative colitis than in moderate to severe disease.
    De Cassan C; Savarino E; Marson P; Tison T; Hatem G; Sturniolo GC; D'Incà R
    World J Gastroenterol; 2014 Dec; 20(45):17155-62. PubMed ID: 25493030
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors associated with exacerbation of newly diagnosed mild ulcerative colitis based on a nationwide registry in Japan.
    Kuwahara E; Murakami Y; Nakamura T; Inoue N; Nagahori M; Matsui T; Watanabe M; Suzuki Y; Nishiwaki Y
    J Gastroenterol; 2017 Feb; 52(2):185-193. PubMed ID: 27075755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Study of the Epidemiology, Clinical, and Phenotypic Characteristics of Inflammatory Bowel Disease in the Northen-Central Region of Saudi Arabia.
    Al-Fawzan AA; Al-Radhi SA; Al-Omar AS; Al-Mutiri NH; Al-Ammari AM; El-Gohary M; Shamsan AN; Al Shehri HM; ALGhasab NS
    Diagnostics (Basel); 2023 Jun; 13(13):. PubMed ID: 37443529
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparing the clinical outcomes of young-onset and adult-onset ulcerative colitis: a multi-center Korean Association for the Study for Intestinal Diseases study.
    Kim JY; Park DI; Han DS; Huh KC; Lee CK; Shin JE; Kim JH; Kim YS; Jung Y; Jung SA; Song HJ; Jang HJ; Kim YH; Hong SN
    Korean J Intern Med; 2017 Jan; 32(1):69-78. PubMed ID: 27338135
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical status, psychosocial impairments, medical treatment and health care costs for patients with inflammatory bowel disease (IBD) in Germany: an online IBD registry.
    Bokemeyer B; Hardt J; Hüppe D; Prenzler A; Conrad S; Düffelmeyer M; Hartmann P; Hoffstadt M; Klugmann T; Schmidt C; Weismüller J; Mittendorf T; Raspe H
    J Crohns Colitis; 2013 Jun; 7(5):355-68. PubMed ID: 22503168
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Demographic and Clinical Characteristics of Ulcerative Colitis in a Northeast Brazilian Population.
    da Silva BC; Lyra AC; Mendes CM; Ribeiro CP; Lisboa SR; de Souza MT; Portela RC; Santana GO
    Biomed Res Int; 2015; 2015():359130. PubMed ID: 26509150
    [TBL] [Abstract][Full Text] [Related]  

  • 38. E-health: Web-guided therapy and disease self-management in ulcerative colitis. Impact on disease outcome, quality of life and compliance.
    Elkjaer M
    Dan Med J; 2012 Jul; 59(7):B4478. PubMed ID: 22759851
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral tacrolimus as maintenance therapy for refractory ulcerative colitis--an analysis of outcomes in two London tertiary centres.
    Landy J; Wahed M; Peake ST; Hussein M; Ng SC; Lindsay JO; Hart AL
    J Crohns Colitis; 2013 Dec; 7(11):e516-21. PubMed ID: 23623737
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The severity of inflammation at onset of ulcerative colitis is not associated with IBS-like symptoms during clinical remission.
    Jonefjäll B; Simrén M; Öhman L; Lasson A; Svedlund J; Strid H
    J Crohns Colitis; 2015 Sep; 9(9):776-83. PubMed ID: 26079726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.